%0 Journal Article %A Lu Han %A Tim Doran %A Richard Ian Gregory Holt %A Catherine Hewitt %A Rowena Jacobs %A Stephanie Louise Prady %A Sarah Louise Alderson %A David Shiers %A Han-I Wang %A Sue Bellass %A Simon Gilbody %A Charlotte Emma Wray Kitchen %A Jennie Lister %A Johanna Taylor %A Najma Siddiqi %T The impact of severe mental illness on healthcare use and health outcomes for people with type 2 diabetes %D 2021 %R 10.3399/BJGP.2020.0884 %J British Journal of General Practice %P BJGP.2020.0884 %X Background: People with severe mental illnesses (SMI) have reduced life expectancy compared with the general population. Diabetes is a major contributor to this disparity with higher prevalence and poorer outcomes in people with SMI. Aim: To determine the impact of SMI on healthcare processes and outcomes for diabetes. Design and setting: Retrospective observational matched nested case-control study using patient records from the Clinical Practice Research Datalink linked to Hospital Episode Statistics. Methods: We compared a range of healthcare processes (primary care consultations, physical health checks, metabolic measurements) and outcomes (prevalence and hospitalisation for cardiovascular disease (CVD), and mortality risk) for 2,192 people with SMI and type 2 diabetes (cases) with 7,773 people with diabetes alone (controls). Socio-demographics, comorbidity and medication prescription were covariates in regression models. Results: SMI was associated with increased risk of all-cause mortality (Hazard Ratio [HR]: 1.92; 95% CI: 1.60 to 2.30) and CVD-specific mortality (HR: 2.24; 1.55 to 3.25); higher physician consultation rates (Incidence Rate Ratio [IRR]: 1.15; 1.11 to 1.19); more frequent checks of blood pressure (IRR: 1.02; 1.00 to 1.05) and cholesterol (IRR: 1.04; 1.02 to 1.06); lower prevalence of angina (Odds Ratio [OR]: 0.67; 0.45 to 1.00); higher emergency admissions for angina (IRR: 1.53; 1.07 to 2.20) and lower elective admissions for ischaemic heart disease (IRR: 0.68; 0.51 to 0.92). Conclusion: Monitoring of metabolic measurements was comparable for people with diabetes with and without SMI. Increased mortality rates observed in SMI may be attributable to under-diagnosis of CVD and delays in treatment. %U https://bjgp.org/content/bjgp/early/2021/02/10/BJGP.2020.0884.full.pdf